Tech Company Financing Transactions
3-V Biosciences Funding Round
3-V Biosciences secured a $20 million Series C investment round on 6/24/2013. Investors included Kleiner Perkins Caufield & Byers and New Enterprise Associates.
Transaction Overview
Kleiner Perkins Caufield & Byers (Beth Seidenberg)
New Enterprise Associates (Robert Garland)
Company Information
Menlo Park, CA 94025
USA
Management Team
Browse more venture capital transactions:
Prev: 6/24/2013: ZocDoc venture capital transaction
Next: 6/24/2013: PLAiR venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs